Table I. —Summary of PEDro score.25-51.
Inclusion study | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Alingh 28 | √ | √ | √ | √ | √ | √ | √ | √ | √ | 8 | ||
Wright 29 | √ | √ | √ | √ | √ | √ | √ | √ | √ | 8 | ||
Husemann 35 | √ | √ | √ | √ | √ | √ | √ | √ | √ | 8 | ||
Bang 36 | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | 9 | |
Miyagawa 41 | √ | √ | √ | √ | √ | √ | √ | √ | 7 | |||
Yu 48 | √ | √ | √ | √ | √ | √ | √ | √ | √ | 8 | ||
Louie 38 | √ | √ | √ | √ | √ | √ | √ | √ | √ | 8 | ||
Li 32 | √ | √ | √ | √ | √ | √ | √ | 6 | ||||
Meng 30 | √ | √ | √ | √ | √ | √ | √ | √ | √ | 8 | ||
Watanabe 42 | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | 10 |
Watanabe 34 | √ | √ | √ | √ | √ | √ | √ | √ | √ | 8 | ||
Zhang 50 | √ | √ | √ | √ | √ | √ | √ | √ | √ | 8 | ||
Lee 51 | √ | √ | √ | √ | √ | √ | √ | √ | 7 | |||
Yoo 26 | √ | √ | √ | √ | √ | √ | √ | 6 | ||||
Aprile 40 | √ | √ | √ | √ | √ | √ | 5 | |||||
Hidler 43 | √ | √ | √ | √ | √ | √ | √ | 6 | ||||
Chua 37 | √ | √ | √ | √ | √ | √ | √ | √ | √ | 8 | ||
Westlake 45 | √ | √ | √ | √ | √ | √ | √ | √ | √ | 8 | ||
Lewek 25 | √ | √ | √ | √ | √ | √ | √ | √ | 7 | |||
Van Nunen 46 | √ | √ | √ | √ | √ | √ | √ | √ | √ | 8 | ||
Pohl 47 | √ | √ | √ | √ | √ | √ | √ | √ | √ | 8 | ||
Tanaka 31 | √ | √ | √ | √ | √ | √ | √ | 6 | ||||
Bizovičar 44 | √ | √ | √ | √ | √ | √ | √ | 6 | ||||
Mustafaoglu 27 | √ | √ | √ | √ | √ | √ | √ | √ | 7 | |||
Pournajaf 49 | √ | √ | √ | √ | √ | √ | √ | 6 | ||||
Tanaka 33 | √ | √ | √ | √ | √ | √ | 5 | |||||
Nam39 | √ | √ | √ | √ | √ | √ | √ | √ | √ | 8 |
1: eligibility criteria; 2: randomly allocated; 3: assigning concealment; 4: similar at baseline; 5: blinding of all subjects; 6: blinding of all therapists; 7: blinding of all assessors; 8: measures of at least one key outcome; 9: intention to treat; 10: comparison between groups; 11: point measures and measures of variability.